Patriot Financial Group Insurance Agency, LLC Myriad Genetics Inc Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$22.67 - $28.01 $9,068 - $11,204	-400 Closed	0 $0
Q4 2020 Jan 15, 2021	BUY	$12.16 - $19.77 $4,864 - $7,908	400 New	400 $8,000
Q2 2019 Aug 07, 2019	SELL	$22.67 - $35.0 $181 - $280	-8 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$27.23 - $45.56 $217 - $364	8 New	8 $0

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$205 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$139 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$90.7 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$69.9 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$63.5 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account